UNSPSC 51161705: Ipratropium bromide

This classification denotes a bronchodilator and antimuscarinic agent with the molecular formula C20H30NO3.Br.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J697UZ2A9J, chemically known as 3-alpha-hydroxy-8-isopropyl-1-alpha-h,5-alpha-h-tropanium bromide (+-)-tropate but generally known as ipratropium bromide, which bears US NIH Compound Identifier 31098. European Medicines Agency schedules Ipratropium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08276MIG.

UNSPSC 51161705 Ipratropium bromide is a Commodity code nominally designating a bronchodilator medication, but recent state and local procurement activity under this code shows a significant mismatch. The two most recent solicitations posted in 2026 target naloxone and pharmacy services — neither of which align with ipratropium bromide's therapeutic scope. Seminole County, Florida solicited naloxone and drug deactivation systems through competitive bidding, while Hall County, Georgia issued an RFQ/P for on-site pharmacy services covering a formulary of 25 medications. The code appears to carry limited activity directly related to ipratropium bromide procurement by state and local entities, with no recent opportunities explicitly naming this medication as a line item or contract focus.

Activity under this code is geographically sparse and limited to Florida and Georgia based on the available 2026 postings. Seminole County's IFB (IFB60459723LAS) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline and quarterly deliveries to the Seminole County Community Health Building in Sanford. Hall County's RFQ/P #47-010, posted May 4, 2026, solicited on-site pharmacy services for the Hall County Government Family Health Center Clinic with a June 4, 2026 response deadline and an initial one-year term beginning January 1, 2027. Neither opportunity directly reflects ipratropium bromide purchasing; the code shows little relevant recent activity and suggests a potential taxonomy misalignment in how state and local procurement offices have tagged these health-services opportunities.